Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck

Key facts

Sponsor

ECOG-ACRIN Cancer Research Group

Principal Investigator

David J Sher, MD

ECOG-ACRIN Cancer Research Group

Intervention

Carboplatin(drug)

Enrollment

290 enrolled

Eligibility

18 years · All sexes

Timeline

2023 – 2030

Study locations (30)

• Moffitt Cancer Center-International Plaza, Tampa, Florida, United States
• Moffitt Cancer Center - McKinley Campus, Tampa, Florida, United States
• Moffitt Cancer Center, Tampa, Florida, United States
• Emory University Hospital Midtown, Atlanta, Georgia, United States
• Saint Luke's Cancer Institute - Boise, Boise, Idaho, United States
• Saint Luke's Cancer Institute - Fruitland, Fruitland, Idaho, United States
• Saint Luke's Cancer Institute - Meridian, Meridian, Idaho, United States
• Saint Luke's Cancer Institute - Nampa, Nampa, Idaho, United States
• Saint Luke's Cancer Institute - Twin Falls, Twin Falls, Idaho, United States
• University of Illinois, Chicago, Illinois, United States
• Carle at The Riverfront, Danville, Illinois, United States
• Carle Physician Group-Effingham, Effingham, Illinois, United States
• Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, United States
• Carle Cancer Center, Urbana, Illinois, United States
• Mission Cancer and Blood - Ankeny, Ankeny, Iowa, United States
• +15 more locations on ClinicalTrials.gov

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Squamous cell carcinoma of oral cavity and lip

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE2NCT07195734
  Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
  National Cancer Institute (NCI)
• RECRUITINGNANCT07264036
  Velopharyngeal Dysfunction in Head & Neck Cancer Patients, Pilot Study
  Vanessa Torrecillas
• RECRUITINGPHASE2NCT07121595
  Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial
  University of Michigan Rogel Cancer Center
• RECRUITINGNCT05837221
  Microbiome in Head and Neck Squamous Cell Carcinoma
  University of Colorado, Denver
• RECRUITINGPHASE2NCT05576974
  A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)
  University of Texas Southwestern Medical Center
• RECRUITINGPHASE1, PHASE2NCT06265025
  GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors
  GeneMedicine Co., Ltd.
• RECRUITINGNANCT05811936
  The SNAP Tool for Head and Neck Cancer Survivor-Caregiver Dyads
  Medical University of South Carolina
• ACTIVE NOT RECRUITINGPHASE1NCT05820711
  Study Transplanting Bone Marrow Cells Into Salivary Glands to Treat Dry Mouth Caused by Radiation Therapy
  University of Wisconsin, Madison

See all trials for Squamous cell carcinoma of oral cavity and lip →